Fludarabine is a purine analogue that has replaced traditional alkylating agent based standard initial treatment of Chronic Lymphocytic Leukemia (CLL)

Fludarabine is a purine analogue that has replaced traditional alkylating agent based standard initial treatment of Chronic Lymphocytic Leukemia (CLL) owing to higher response rates and greater survival advantage.

 

Indication:

FLUDAMAX for injection is indicated for the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen

Generic Name

Strength

Standard

Type

Packing

Pack Size

Fludarabine

50 mg

USP

INJ

Vial

 ml